Altern Ther Health Med. 2023 Nov;29(8):342-346.
Acute appendicitis (AA) is a prevalent abdominal emergency in children, and there has been growing interest in the use of endoscopic retrograde appendicitis treatment (ERAT) over the past two decades. A meta-analysis of published retrospective studies was conducted to investigate the clinical characteristics and therapeutic efficacy of ERAT for AA in children.
A systematic review and meta-analysis of retrospective studies were carried out, encompassing data from PUBMED, MEDLINE, Cochrane, China National Knowledge Infrastructure (CNKI), WanFang, and VIP Database. The search was limited to studies published between January 1, 2012, and June 31, 2022, with the final search conducted on October 31, 2022. No restrictions were imposed regarding publication or study design filters. The registration number in PROSPERO was CRD42022377739.
Seven retrospective cohort studies with 423 patients were included. The majority of children who underwent ERAT were male (57.6%, 95% CI 52.8%-62.4%). The ERAT procedure had a high success rate (99.5%, 95% CI 98.2%-100.0%) and averaged around 49 minutes. ERAT's efficacy for treating acute appendicitis was high (99.0%, 95% CI 96.5%-100.0%), with a low recurrence rate (4.2%, 95% CI 2.2%-6.7%). Patients typically stayed in the hospital for about 4.3 days, and the rate of postoperative complications was around 3.9% (95% CI 2.0%-6.2%).
Despite the heterogeneity among studies, ERAT appears to be an effective treatment for acute uncomplicated appendicitis in children. It has a high success rate, a low recurrence rate, preserves the appendix's function, and causes minimal damage. ERAT could be considered a safe and effective treatment option for pediatric appendicitis.
急性阑尾炎(AA)是儿童常见的腹部急症,在过去的二十年中,内镜逆行阑尾炎治疗(ERAT)的应用越来越受到关注。对已发表的回顾性研究进行了荟萃分析,以调查 ERAT 治疗儿童 AA 的临床特征和治疗效果。
对 PUBMED、MEDLINE、Cochrane、中国知网(CNKI)、万方和 VIP 数据库进行了系统的回顾和荟萃分析,检索范围限于 2012 年 1 月 1 日至 2022 年 6 月 31 日发表的研究,最终检索日期为 2022 年 10 月 31 日。对发表状态或研究设计筛选没有任何限制。PROSPERO 注册号为 CRD42022377739。
纳入了 7 项回顾性队列研究,共 423 例患儿。接受 ERAT 的患儿多为男性(57.6%,95%可信区间 52.8%-62.4%)。ERAT 操作成功率高(99.5%,95%可信区间 98.2%-100.0%),平均用时约 49 分钟。ERAT 治疗急性阑尾炎的疗效高(99.0%,95%可信区间 96.5%-100.0%),复发率低(4.2%,95%可信区间 2.2%-6.7%)。患者通常住院约 4.3 天,术后并发症发生率约为 3.9%(95%可信区间 2.0%-6.2%)。
尽管研究间存在异质性,但 ERAT 似乎是治疗儿童急性单纯性阑尾炎的有效方法。它具有成功率高、复发率低、保留阑尾功能和损伤小的优点。ERAT 可被视为治疗小儿阑尾炎的一种安全有效的治疗选择。